OCCIDENT invests in Immitra Bio
OCCIDENT Participates in Immitra Bio’s CHF 2.4 million Pre-Seed Round.
As a venture capital investor, we support start-ups from the seed stage onwards and enable founding teams to achieve outstanding results. With a strong entrepreneurial mindset, we invest our own money and make decisions based on sustainable potential for success.
The Science Investor.